1 OMEPRAZOLE | 1310 of 3340 | 1400 prescriptions Less than 1% of all prescriptions | 1140 | 590 patients 20% of all patients | 480 patients 16% of all patients | |
2 PANTOPRAZOLE SODIUM | 1420 of 3360 | 1380 prescriptions Less than 1% of all prescriptions | 1120 | 530 patients 18% of all patients | 410 patients 14% of all patients | |
3 RANITIDINE HCL | 930 of 2630 | 730 prescriptions Less than 1% of all prescriptions | | 290 patients 10% of all patients | < 11 | |
4 AMITIZA (LUBIPROSTONE) | 420 of 1740 | 290 prescriptions Less than 1% of all prescriptions | | 130 patients 4% of all patients | < 11 | |
5 CREON (LIPASE/PROTEASE/AMYLASE) | 90 of 1180 | 480 prescriptions Less than 1% of all prescriptions | 290 | 140 patients 5% of all patients | < 11 | |
6 LINZESS (LINACLOTIDE) | 780 of 2590 | 240 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
7 ZENPEP (LIPASE/PROTEASE/AMYLASE) | 20 of 220 | 310 prescriptions Less than 1% of all prescriptions | | < 11 | < 11 | |
8 ONDANSETRON ODT (ONDANSETRON) | 210 of 1160 | 320 prescriptions Less than 1% of all prescriptions | | 190 patients 6% of all patients | < 11 | |
9 HUMIRA PEN (ADALIMUMAB) | 300 of 910 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
10 CARAFATE (SUCRALFATE) | 290 of 800 | 110 prescriptions Less than 1% of all prescriptions | 110 | < 11 | < 11 | |
11 LEVOFLOXACIN | 20 of 110 | 220 prescriptions Less than 1% of all prescriptions | 220 | 220 patients 7% of all patients | 220 patients 7% of all patients | A |
12 GAVILYTE-N (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 300 of 1120 | 690 prescriptions Less than 1% of all prescriptions | 500 | 670 patients 22% of all patients | 490 patients 16% of all patients | |
13 PEG 3350-ELECTROLYTE (SODIUM CHLORIDE/NAHCO3/KCL/PEG) | 290 of 1010 | 460 prescriptions Less than 1% of all prescriptions | 330 | 420 patients 14% of all patients | 310 patients 10% of all patients | |
14 MOVIPREP (PEG3350/SOD SUL/NACL/KCL/ASB/C) | 300 of 580 | 160 prescriptions Less than 1% of all prescriptions | | 140 patients 5% of all patients | < 11 | |